1261 Results for "

Cereblon ligand

" in MedChemExpress (MCE) Product Catalog:
Products (1261)

1261 Results for "Cereblon ligand" in MCE Product Catalog:

40
40 Publications Verification
Cat. No.: HY-112588
CAS No.: 1950634-92-0
Purity:  99.90%
dBET6 is a highly potent, selective and cell-permeable PROTAC connected by ligands for Cereblon and BET, with an IC50 of 14 nM, and has antitumor activity.
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-101838
CAS No.: 1799711-21-9
Purity:  98.96%
Research Areas:  

Cancer

dBET1 is a PROTAC connected by ligands for Cereblon and BRD4 with an EC50 of 430 nM. dBET1 is a PROTAC that composes of (+)-JQ1 (HY-13030) linked to NSC 527179 (HY-14658) with a linker .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-134582
CAS No.: 2484739-25-3
Purity:  99.37%
dCBP-1 is a potent and selective heterobifunctional degrader of p300/CBP based on Cereblon ligand. dCBP-1 is exceptionally potent at killing multiple myeloma cells and ablates oncogenic enhancer activity driving MYC expression .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-129602
CAS No.: 2429877-44-9
Purity:  99.73%
Target:  

PROTACs STAT Apoptosis

Research Areas:  

Cancer

SD-36 is a potent and efficacious STAT3 PROTAC degrader (Kd=~50 nM), and demonstrates high selectivity over other STAT members. SD-36 also effectively degrades mutated STAT3 proteins in cells and suppresses the transcriptional activity of STAT3 (IC50=10 nM). SD-36 exerts robust anti-tumor activity, and achieves complete and long-lasting tumor regression in mouse tumor models. SD-36 is composed of the STAT3 inhibitor SI-109, a linker, and an analog of Cereblon ligand Lenalidomide for E3 ubiquitin ligase . SD-36 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-114312
CAS No.: 2136247-12-4
Purity:  99.60%
Research Areas:  

Cancer

MD-224 is a first-in-class and highly potent small-molecule human murine double minute 2 (MDM2) degrader based on the proteolysistargeting chimera (PROTAC) concept. MD-224 consists of ligands for Cereblon and MDM2. MD-224 induces rapid degradation of MDM2 at concentrations <1 nM in human leukemia cells, and achieves an IC50 value of 1.5 nM in inhibition of growth of RS4;11 cells. MD-224 has the potential to be a new class of anticancer agent . MD-224 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-139039
CAS No.: 2519823-34-6
Purity:  98.73%
Target:  

PROTACs CDK

Research Areas:  

Cancer

BSJ-4-116 is a PROTAC connected by ligands for Cereblon and CDK. BSJ-4-116 is a highly potent and selective CDK12 degrader (PROTAC) with an IC50 of 6 nM. BSJ-4-116 downregulates DDR genes through a premature termination of transcription, primarily through increasing poly(adenylation). BSJ-4-116 exhibits potent antiproliferative effects, alone and in combination with the poly(ADP-ribose) polymerase inhibitor Olaparib (HY-10162) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-153321
CAS No.: 2649400-34-8
Purity:  98.67%
Synonyms: NX-5948; BTK-IN-24
Target:  

PROTACs Btk

Research Areas:  

Inflammation/Immunology

Bexobrutideg (NX-5948) is an orally active chimeric targeting molecule (CTM) that induces specific BTK protein degradation by the cereblon E3 ligase (CRBN) complex without degradation of other cereblon neo-substrates. Bexobrutideg mediates potent anti-inflammatory activity via BTK degradation with resultant inhibition of B cell activation. Bexobrutideg exhibits potent tumor growth inhibition in TMD8 xenograft models that contain either wild-type BTK or BTKi-resistant mutations. Bexobrutideg is efficacious in a mouse collageninduced arthritis (CIA) model. Bexobrutideg can cross the blood brain barrier (BBB). Bexobrutideg is a PROTAC composed of the ligand for target protein, a linker, and a cereblon E3 ligase (CRBN) complex (Red: BTK ligand (HY-170324); Blue: CRBN ligand (HY-171893); Black: linker) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-103632
CAS No.: 2097971-01-0
Purity:  99.16%
Research Areas:  

Cancer

PROTAC BRD9 Degrader-1 is a PROTAC connected by ligands for Cereblon and BRD9 (IC50=13.5 nM), which can be used as a selective probe useful for the study of BAF complex biology .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-103597
CAS No.: 1061605-21-7
Purity:  99.85%
Synonyms: Cereblon ligand 3; E3 ligase ligand 3
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

Thalidomide-O-COOH (Cereblon ligand 3) is the Thalidomide-based Cereblon ligand used in the recruitment of CRBN protein. Thalidomide-O-COOH (Cereblon ligand 3) can be connected to the ligand for protein by a linker to form PROTACs .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-103628
CAS No.: 2118356-96-8
Purity:  99.55%
Target:  

PROTACs CDK

Research Areas:  

Cancer

PROTAC CDK9 Degrader-1 is a PROTAC connected by ligands for Cereblon and CDK as a selective CDK9 degrader.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-111518
CAS No.: 2209085-22-1
Purity:  99.82%
Target:  

PROTACs CDK

Research Areas:  

Cancer

JH-XI-10-02 is a PROTAC connected by ligands for Cereblon and CDK. JH-XI-10-02 is a highly potent and selective PROTAC CDK8 degrader, with an IC50 of 159 nM. JH-XI-10-02 causes proteasomal degradation, does not affect CDK8 mRNA levels. JH-XI-10-02 shows no effect on CDK19 .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-133120
CAS No.: 2503017-97-6
Purity:  99.74%
Target:  

PROTACs Akt

Research Areas:  

Cancer

INY-03-041 is a potent, highly selective and PROTAC-based pan-AKT degrader consisting of the ATP-competitive AKT inhibitor Ipatasertib (HY-15186) conjugated to Lenalidomide (HY-A0003, Cereblon ligand). INY-03-041 inhibits AKT1, AKT2 and AKT3 with IC50s of 2.0, 6.8 and 3.5 nM, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103614
CAS No.: 1950635-16-1
Purity:  99.43%
Synonyms: Cereblon ligand -Linker Conjugates 2 TFA; E3 Ligase ligand-Linker Conjugates 20 TFA
Thalidomide-O-amido-C8-NH2 TFA (Cereblon Ligand -Linker Conjugates 2 TFA) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103615
CAS No.: 2098488-36-7
Purity:  98.36%
Synonyms: Cereblon ligand-Linker Conjugates 4; E3 ligase ligand-Linker Conjugates 18
Research Areas:  

Others

Thalidomide-O-amido-C4-N3 is a synthetic E3 ligase ligand-linker conjugate, consisting of a cereblon ligand based on Thalidomide (HY-14658) and a linker .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-130714
CAS No.: 2305936-56-3
Purity:  99.41%
Target:  

PROTACs

Research Areas:  

Cancer

TD-165 is a PROTAC-based cereblon (CRBN) degrader. TD-165 comprises a cereblon (CRBN) ligand binding group, a linker and an von Hippel-Landau (VHL) binding group .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103634
CAS No.: 1799711-22-0
Purity:  95.03%
Target:  

PROTACs FKBP

Research Areas:  

Cancer

dFKBP-1 is a potent and PROTAC-based FKBP12 degrader. dFKBP-1 incorporates the ligand SLF (HY-114872) of FKBP12, the Thalidomide based Cereblon ligand and a linker .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125876
CAS No.: 2378801-85-3
Purity:  99.80%
Target:  

PROTACs Bcl-2 Family

Research Areas:  

Cancer

PROTAC Bcl2 degrader-1 (Compound C5) is a PROTAC based on Cereblon ligand, which potently and selectively induces the degradation of Bcl-2 (IC50, 4.94 μM; DC50, 3.0 μM) and Mcl-1 (IC50, 11.81 μM) by introducing the E3 ligase cereblon (CRBN)-binding ligand pomalidomide to Mcl-1/Bcl-2 dual inhibitor Nap-1 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-131717
CAS No.: 927670-97-1
Purity:  98.07%
Research Areas:  

Cancer

Thalidomide-NH-CH2-COOH is the Thalidomide-based cereblon ligand used in the recruitment of CRBN protein. Thalidomide-NH-CH2-COOH can be connected to the ligand for protein by a linker to form PROTACs, such as THAL-SNS-032 (HY-123937) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125835
CAS No.: 2366268-80-4
Purity:  98.41%
Target:  

PROTACs CDK

Research Areas:  

Cancer

CP-10 is a PROTAC connected by ligands for Cereblon and CDK, with highly selective, specific, and remarkable CDK6 degradation (DC50=2.1 nM). It inhibits proliferation of several haematopoietic cancer cells with impressive potency including multiple myeloma, and can still degrades mutated and overexpressed CDK6 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-140844
CAS No.: 2380318-57-8
Purity:  98.02%
Thalidomide-O-PEG4-azide is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. Thalidomide-O-PEG4-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
loading...
    loading...